Pieter Sonneveld

Filter

2022
MM-153 Phase 2 CARTITUDE-2 Study (Cohort B): Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients With Multiple Myeloma (MM) and Early Relapse After Initial Therapy
Agha, M., Van de Donk, N. W., Cohen, A. D., Cohen, Y. C., Anguille, S., Kerre, T., Roeloffzen, W., Schecter, J. M., de Braganca, K. C., Varsos, H., Mistry, P., Roccia, T., Zudaire, E., Corsale, C., Akram, M., Geng, D., Nesheiwat, T., Pacaud, L., Sonneveld, P. & Zweegman, S., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S408-S409
Research output: Contribution to journal › Meeting Abstract › Academic › peer-review
1 Citation (Scopus)

prof. dr. Pieter Sonneveld